Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?

Area of Science:

• Biochemistry
• Oncology
• Immunology

Background:

• Certain cancer cells rely on oxidative phosphorylation (OXPHOS) for survival.
• Increased OXPHOS dependency is a characteristic of cancer stem cells and drug-resistant cells.
• Modulating OXPHOS can impact the tumor microenvironment, reducing hypoxia and enhancing anti-tumor immunity.

Purpose of the Study:

• To provide an overview of OXPHOS complexes, their role in cancer, and their potential as therapeutic targets.
• To discuss current research tools and models for studying OXPHOS in cancer.
• To review the development status of OXPHOS inhibitors and strategies for their clinical application.

Main Methods:

• Literature review and synthesis of current research on OXPHOS in cancer.
• Analysis of the structure, function, and biological roles of OXPHOS complexes.
• Evaluation of existing and emerging therapeutic strategies targeting OXPHOS.

Main Results:

• OXPHOS is essential for specific cancer subtypes, including cancer stem cells and therapy-resistant cells.
• Inhibition of OXPHOS presents a promising anti-cancer strategy with potential to modulate the tumor microenvironment.
• Various therapeutic agents targeting OXPHOS are under development.

Conclusions:

• Targeting OXPHOS is a viable strategy for cancer treatment, with potential to overcome resistance and enhance immune response.
• Further research and development of OXPHOS inhibitors are crucial for clinical translation.
• Understanding OXPHOS limitations as drug targets is key to optimizing therapeutic strategies.